No Data
No Data
Emerging market prospects: Circulatory selection within the biotechnology sector is booming, but the improvement of investor sentiment depends on timing.
Due to the downturn in high-tech stocks and the appreciation of the yen in the foreign markets, investor sentiment has worsened, leading to a significant drop in the emerging markets this week. During the same period, while the Nikkei Average fell by -5.98%, the growth market index fell by -4.50% and the growth market 250 index fell by -4.86%, experiencing a sharp decline. Like the main board market, investor sentiment has also soured in response to the decline of high-tech stocks and the appreciation of the yen in the foreign markets. This has led to a stronger selling pressure, particularly in bio stocks that had been rapidly rising. This is the market trend of the week.
The Tokyo Stock Exchange's Growth Market 250 Index rebounded for the third day and was in a firm condition in comparison to large-cap stocks.
The Tokyo Stock Exchange Growth Market Index was 828.76, up 2.40, with a volume of 0.2 billion and 52.74 million shares traded, and a turnover of 152.3 billion yen. The TSE Growth Market 250 Index was 642.91, up 2.35, with a volume of 0.1 billion and 47.2 million shares traded, and a turnover of 65.8 billion yen. Today's Growth Market saw a rebound in both the TSE Growth Market Index and the TSE Growth Market 250 Index, both up for the first time in three days. The number of rising stocks was 262, the number of declining stocks was 281, and the number of unchanged stocks was 40. The US stock market on the 25th was mixed. The Dow Average was up 81.20 dollars.
Chordia Therapeutics, Simbio Pharmaceuticals, etc.
<190A> Chordia Therapeutics Co., Ltd. SBI Investment Co., Ltd. shareholding ratio 6.42% → 8.73% Reporting obligation start date 2024/07/18 <202A> Mamezou Digital Holdings Co., Ltd. Mamezou K2 Top Holdings Co., Ltd. shareholding ratio 71.78% → 67.99% Reporting obligation start date 2024/07/24 <2164> Regional Newspaper Co., Ltd. Engi Co., Ltd.
Insider decrases its stake in SymBio Pharmaceuticals(4582.JP) to 4.18%
On Jul 25, ハイツ・キャピタル・マネジメント・インク submitted the Change Report to Ministry of Finance. The report shows that ハイツ・キャピタル・マネジメント・インク decreased their holdings in $SymBio Pharmaceuticals(4582.JP)$, with
The Tokyo Stock Exchange's 250 Gross Market Index fell sharply and expanded its decline due to the pullback of large cap stocks, although it rebounded.
Tokyo Stock Exchange growth market index is at 836.81, down 14.26, with a volume of 98.64 million shares and a turnover of JPY 132.1 billion. Tokyo Stock Exchange Growth Market 250 Index is at 648.21, down 12.69, with a volume of 62.32 million shares and a turnover of JPY 90.3 billion. Today's growth market saw significant declines in both the Tokyo Stock Exchange growth market index and the Tokyo Stock Exchange Growth Market 250 Index. There were 144 advancing stocks, 412 declining stocks, and 28 unchanged stocks. On the 23rd, the US stock market fell, with the Dow Jones Industrial Average dropping by 57.35 dollars.
The Tokyo Stock Exchange Growth Market Index fell for the third day, and overall weakness was evident in the growth market on the first day.
The Tokyo Stock Exchange Growth Market Index is at 846.29, down 21.50 with a volume of 0.22538 billion shares and a turnover of JPY 121.6 billion. The Tokyo Stock Exchange Growth Market 250 index is at 657.25, down 18.48, with a volume of 0.13369 billion shares and a turnover of JPY 95.8 billion. In today's Growth Market, the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index have fallen for three consecutive business days. There are 124 advancing stocks, 432 declining stocks, and 28 unchanged. On the 19th in the US market, the Dow average fell by 377.49 dollars.
No Data